ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646395 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646395; 2) Community: the network communities that were significantly associated with the response to NSC 646395; 3) Molecule: the relationships between components within communities and NSC 646395; 4) MDR: the compounds that were significantly associated with the NSC 646395.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0237269271456697 -0.2047266
NSC 732492 Null 0.0237269271456697 0.073285944
NSC 743695 Null 0.0237269271456697 0.16779676
NSC 744688 Null 0.0237269271456697 0.12323014
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0237269271456697 0.2731683
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0237269271456697 0.19260828
NSC 750050 Null 0.0237269271456697 0.21528595
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0237269271456697 0.055851158
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0237269271456697 0.18149381
NSC 756401 GW832467X 0.0237269271456697 -0.083506404
Total:99  Current:55    [First] [Prev] [Next] [Last]